Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 5, 2013, Pages 425-426

  Matito, Almudena ^a   Blázquez Goñi, Cristina ^b   Morgado, Jose M ^a   Álvarez Twose, Iván ^a   Mollejo, Manuela ^c   Sánchez Muñoz, Laura ^a   Escribano, Luis ^d  

^a Instituto de Estudios de Mastocitosis de Castilla la Mancha   (Spain)

^b HOSPITAL DE JEREZ   (Spain)

^c HOSPITAL VIRGEN DE LA SALUD   (Spain)

^d Centro de Investigacion del Cancer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CROMOGLYCATE DISODIUM; FLUTICASONE FUROATE; IMMUNOGLOBULIN E; METHYLPREDNISOLONE; OMALIZUMAB; PREDNISONE; SALMETEROL; TRYPTASE;

ALLERGIC ASTHMA; ANAPHYLAXIS; BRONCHOSPASM; CASE REPORT; CHILD; DERMATOPHAGOIDES; DIARRHEA; DYSPNEA; ERYTHEMA; FACE EDEMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LETTER; MAST CELL; PRIORITY JOURNAL; PRURITUS; SCHOOL CHILD; SKIN BIOPSY; SPAIN; URTICARIA PIGMENTOSA; WHEEZING;

EID: 84885950853     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.08.014     Document Type: Article

References (10)

1. L.A. Beck, G.V. Marcotte, D. MacGlashan, A. Togias, and S. Saini Omalizumab-induced reductions in mast cell Fcepsilon RI expression and function J Allergy Clin Immunol 114 2004 527 530
2. J.M. Oliver, C.A. Tarleton, and L. Gilmartin Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy Int Arch Allergy Immunol 151 2010 275 284
3. A.P. Kaplan, K. Joseph, R.J. Maykut, G.P. Geba, and R.K. Zeldin Treatment of chronic autoimmune urticaria with omalizumab J Allergy Clin Immunol 122 2008 569 573
4. P. Warrier, and T.B. Casale Omalizumab in idiopathic anaphylaxis Ann Allergy Asthma Immunol 102 2009 257 258
5. M.C. Carter, J.A. Robyn, P.B. Bressler, J.C. Walker, G.G. Shapiro, and D.D. Metcalfe Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis J Allergy Clin Immunol 119 2007 1550 1551
6. I. Alvarez-Twose, S. Vano-Galvan, and L. Sanchez-Munoz Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis Allergy 67 2012 813 821
7. D. Gonzalez de Olano, B. de la Hoz, and R. Nunez-Lopez Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish Network on Mastocytosis (REMA) Clin Exp Allergy 37 2007 1547 1555
8. K. Brockow, C. Jofer, H. Behrendt, and J. Ring Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients Allergy 63 2008 226 232
9. C.H. Song, S. Stern, M. Giruparajah, N. Berlin, and G.L. Sussman Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria Ann Allergy Asthma Immunol 110 2013 113 117
10. J.A. Douglass, K. Carroll, A. Voskamp, P. Bourke, A. Wei, and R.E. O'Hehir Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient Allergy 65 2010 926 927